Results 61 to 70 of about 1,146,138 (352)

Perceptions of traditional Chinese medicine doctors about using wearable devices and traditional Chinese medicine diagnostic instruments: A mixed-methodology study

open access: yesDigital Health, 2022
Objective This study aimed to investigate the perceptions of traditional Chinese medicine doctors about wearable devices and diagnostic instruments and explore the factors that influence them.
Siyu Zhou   +3 more
doaj   +1 more source

TCM-GPT: Efficient Pre-training of Large Language Models for Domain Adaptation in Traditional Chinese Medicine [PDF]

open access: yesarXiv, 2023
Pre-training and fine-tuning have emerged as a promising paradigm across various natural language processing (NLP) tasks. The effectiveness of pretrained large language models (LLM) has witnessed further enhancement, holding potential for applications in the field of medicine, particularly in the context of Traditional Chinese Medicine (TCM).
arxiv  

Traditional Chinese medicine for cancer? [PDF]

open access: yesBritish Journal of Cancer, 2012
When faced with a diagnosis of cancer, many patients feel they must leave no stone unturned and try alternative treatments, such as traditional Chinese medicine (TCM) (Ernst and Cassileth, 1998). Yet oncologists often know little about such therapies.
openaire   +3 more sources

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

open access: yesMolecular Oncology, EarlyView.
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song   +13 more
wiley   +1 more source

Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes

open access: yesAAPS Open
Curcumin and paclitaxel are widely used as anti-tumor hydrophobic model drugs for the designation of smart tumor-targeting nanocarriers and the study of the correlation between structural characteristics of nanoparticles and in vivo therapeutic efficacy.
Hailing Tang   +3 more
doaj   +1 more source

The spatial distribution of traditional intangible cultural heritage medicine of China and its influencing factors

open access: yesHeritage Science, 2023
Intangible cultural heritage (ICH) of traditional Chinese medicine is a vivid testimony to the continuous inheritance of Chinese civilization. The study of ICH of traditional Chinese medicine from the perspective of the geographical environment, spatial ...
Xin Nie   +3 more
doaj   +1 more source

Traditional Chinese medicine physicians’ insights into inter-professional tensions between traditional Chinese medicine and biomedicine: a critical perspective [PDF]

open access: yes, 2017
In Singapore, the institutional preference for biomedicine and the cultural importance of traditional Chinese medicine (TCM) have created tensions between the two medical systems and erected barriers to a more collaborative healthcare system.
Chang, Leanne, Lim, Jing Ci Jill
core   +1 more source

Applications of Network Pharmacology in Traditional Chinese Medicine Research

open access: yesEvidence-Based Complementary and Alternative Medicine, 2020
Human diseases, especially infectious ones, have been evolving constantly. However, their treatment strategies are not developing quickly. Some diseases are caused by a variety of factors with very complex pathologies, and the use of a single drug cannot
Zhuchen Zhou   +7 more
semanticscholar   +1 more source

Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery

open access: yesFrontiers in Pharmacology, 2021
As an important part of complementary and alternative medicine, traditional Chinese medicine (TCM) has been applied to treat a host of diseases for centuries.
Qiang Sun   +9 more
semanticscholar   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy